Patents by Inventor David R. Moller

David R. Moller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DIAGNOSTIC BLOOD TEST FOR SARCOIDOSIS
    Publication number: 20210278415
    Abstract: Sarcoidosis is a multisystem disease characterized by granulomatous inflammation in affected organs. The present invention discloses kits and a system for a blood test using mycobacterial catalase-peroxidase that has a high positive predictive value for confirming a diagnosis of sarcoidosis.
    Type: Application
    Filed: May 13, 2021
    Publication date: September 9, 2021
    Inventor: David R. Moller
  • Diagnostic blood test for sarcoidosis
    Patent number: 11041862
    Abstract: Sarcoidosis is a multisystem disease characterized by granulomatous inflammation in affected organs. The present invention discloses kits and a system for a blood test using mycobacterial catalase-peroxidase that has a high positive predictive value for confirming a diagnosis of sarcoidosis.
    Type: Grant
    Filed: February 23, 2018
    Date of Patent: June 22, 2021
    Inventor: David R. Moller
  • DIAGNOSTIC BLOOD TEST FOR SARCOIDOSIS
    Publication number: 20180188265
    Abstract: Sarcoidosis is a multisystem disease characterized by granulomatous inflammation in affected organs. The present invention discloses kits and a system for a blood test using mycobacterial catalase-peroxidase that has a high positive predictive value for confirming a diagnosis of sarcoidosis.
    Type: Application
    Filed: February 23, 2018
    Publication date: July 5, 2018
    Inventor: David R. Moller
  • Diagnostic blood test for sarcoidosis
    Patent number: 9977029
    Abstract: Sarcoidosis is a multisystem disease characterized by granulomatous inflammation in affected organs. The present invention discloses kits and a system for a blood test using mycobacterial catalase-peroxidase that has a high positive predictive value for confirming a diagnosis of sarcoidosis.
    Type: Grant
    Filed: November 10, 2015
    Date of Patent: May 22, 2018
    Inventor: David R. Moller
  • Diagnostic blood test for sarcoidosis
    Patent number: 9683999
    Abstract: Sarcoidosis is a multisystem disease characterized by granulomatous inflammation in affected organs. We have developed a blood test using mycobacterial catalase-peroxidase that has a high positive predictive value for confirming a diagnosis of sarcoidosis.
    Type: Grant
    Filed: May 16, 2014
    Date of Patent: June 20, 2017
    Inventor: David R. Moller
  • DIAGNOSTIC BLOOD TEST FOR SARCOIDOSIS
    Publication number: 20160139145
    Abstract: Sarcoidosis is a multisystem disease characterized by granulomatous inflammation in affected organs. The present invention discloses kits and a system for a blood test using mycobacterial catalase-peroxidase that has a high positive predictive value for confirming a diagnosis of sarcoidosis.
    Type: Application
    Filed: November 10, 2015
    Publication date: May 19, 2016
    Inventor: David R. Moller
  • DIAGNOSTIC BLOOD TEST FOR SARCOIDOSIS
    Publication number: 20150192592
    Abstract: Sarcoidosis is a multisystem disease characterized by granulomatous inflammation in affected organs. We have developed a blood test using mycobacterial catalase-peroxidase that has a high positive predictive value for confirming a diagnosis of sarcoidosis.
    Type: Application
    Filed: May 16, 2014
    Publication date: July 9, 2015
    Inventor: David R. Moller